CMC544

Therapeutic focus

Non-Hodgkin’s Lymphoma

Type of molecule

NBE (humanised IgG4 antibody linked to calicheamicin)

Mode of action

A novel cytotoxic chemotherapeutic agent that targets and kills CD22 expressing B-cells

Partner

Wyeth (http://www.wyeth.com/)